Introduction
1. Characteristics of "Autologous Multi-lineage Potential Cells" (AMPC)
• Self-renewal cells have multilineage differentiation
potential
• AMPC was trans-differentiated from adult white blood cells,
the number of stem cells is between 300 million and 1
billion
• There are many types of stem cells, including hematopoietic
stem cells, mesenchymal stem cells, endothelial stem cells,
very small embryonic stem cells (VSEL)
• Homing effect and can identify the parts of the body that
need to be repaired for stem cell regeneration,
simultaneously triggering the body chemical signals
transduction
2. AMPC have multiple differentiation potentials
• Appropriate induction has the ability to transform into
neural cells (ectoderm), osteoblasts (medium germ layer),
cardiomyocytes (mesoderm) and hepatocytes (endoderm)
potentials
3. Advantages of AMPC
• Possess great potential for differentiation and have adjuvant
therapeutic effect on most degenerative diseases, includes
arthritis, leukemia, cardiovascular disease, kidney or liver
disease, and some autoimmune disease
Features / strengths
Personalized regenerative medicine cell product "Autologous Multi – Lineage Potential Cells (AMPC)”characteristics –
- US Patent Number 11,471,485
- Therapeutic Goods Administration (TGA) of Australian
government health management agency agree physician
to infuse AMPC for medical services
- Medical insurance by LLOYD's of London, UK
- AMPC manufacture by closed system
- No antibiotics, exogenous growth factors or genetic
manipulations
- More than 2,000 cases of autologous infusion have been
completed, none any serious adverse reactions
- AMPC is safety and significant medical effects
Specification in detail
Minimal manipulation
The human cell therapy products for the manufacturing or operation process, not process culture in vitro, and the operation process does not change the original biological characteristics of the cells.
